A Asia Pacific Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices)

Asia Pacific Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)

The Asia Pacific glucose monitoring devices market is expected to grow from US$ 3,386.90 million in 2022 to US$ 8,471.46 million by 2030. It is estimated to grow at a CAGR of 12.1% from 2022 to 2030.

Growing Geriatric Population Fuel Asia Pacific Glucose Monitoring Devices Market

Diabetes among the geriatric population is a growing public health burden worldwide. It is a major cause of morbidity and mortality in the aging population that is later largely attributable to various chronic complications. The aging population is poised to become one of the most significant transformations with a heavy impact on the global social and economic level. This population is growing exponentially worldwide. According to the World Health Organization (2022), by 2030, 1 in 6 people will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 or older is expected to triple between 2020 and 2050 to reach 426 million. The number of geriatric populations is expected to grow significantly in Africa, followed by Asia Pacific. Elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly serious in this population. With the increase in the geriatric population, the prevalence of diabetes has increased. Therefore, there is notable demand for glucose monitoring devices.

Asia Pacific Glucose Monitoring Devices Market Overview

The Asia Pacific Glucose Monitoring Devices Market has been segmented into the China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The market growth in China is high attributed to the rising awareness of the diabetes diagnosis. India holds second largest share in terms of continuous glucose monitoring owing to high prevalence of diabetes in the country. The aforementioned factors are responsible for influential growth of Asia Pacific Glucose Monitoring Devices Market in the Asia Pacific region.

Asia Pacific Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Glucose Monitoring Devices Market Segmentation

The Asia Pacific glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the Asia Pacific glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on application, the Asia Pacific glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on testing site, the Asia Pacific glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on end user, the Asia Pacific glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.

Based on country, the Asia Pacific glucose monitoring devices market is segmented int o the China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. China dominated the Asia Pacific glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Asia Pacific glucose monitoring devices market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific glucose monitoring devices market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific glucose monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.